Trilogy International Partners Inc (TSE:TRL) had its target price lowered by equities researchers at TD Securities from C$10.50 to C$10.00 in a research report issued to clients and investors on Tuesday. The firm presently has a “buy” rating on the specialty pharmaceutical company’s stock. TD Securities’ target price indicates a potential upside of 40.25% from the stock’s previous close.

Separately, Scotiabank reduced their price target on Trilogy International Partners from C$12.50 to C$11.00 and set an “outperform” rating on the stock in a research report on Thursday, August 10th.

Trilogy International Partners (TSE:TRL) traded down 0.28% during mid-day trading on Tuesday, reaching $7.11. 19,669 shares of the company’s stock traded hands. The stock’s market capitalization is $314.62 million. Trilogy International Partners has a 12 month low of $5.46 and a 12 month high of $10.48. The firm’s 50-day moving average price is $7.47 and its 200 day moving average price is $8.73.

TRADEMARK VIOLATION NOTICE: “TD Securities Cuts Trilogy International Partners Inc (TRL) Price Target to C$10.00” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at

Trilogy International Partners Company Profile

Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.

Receive News & Stock Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related stocks with our FREE daily email newsletter.